A novel lncRNA FPASL regulates fibroblast proliferation via the PI3K/AKT and MAPK signaling pathways in hypertrophic scar

Authors:

Abstract
Hypertrophic scar (HS) is a problem for numerous patients eagering to solve, especially after burns, and characterized by increased fibroblasts proliferation and collagen deposition. Increasing evidence demonstrate that lncRNAs contribute to development and progression of various diseases. However, the function of lncRNAs in hypertrophic scar formation remains poorly characterized. In this study, a novel fibroblast proliferation-associated lncRNA, named lncRNA FPASL (MSTRG.389905.1), which mainly localized in cytoplasm, is found downregulated in HS as detected by lncRNA microarray and qRT-PCR. Further studies characterize full-length FPASL and confirm that its no protein-coding potential. FPASL knockdown in fibroblasts triggers fibroblasts proliferation, whereas overexpressing FPASL directly attenuates proliferation of fibroblasts. Furthermore, target genes of the differentially expressed lncRNAs in HS and the matched adjacent normal tissues (NS) are enriched in fibroblasts proliferation signaling pathways in HS as determined by GO annotation and KEGG enrichment analysis, including the PI3K/AKT and MAPK signaling pathways. We demonstrate that knockdown of FPASL activates the PI3K/AKT and MAPK signaling pathways and specific inhibitors of PI3K/AKT and MAPK signaling pathways intervention can reverse the promotion of LNA-FPASL on fibroblasts proliferation. These findings contribute to a better understanding of hypertrophic scar in relation to lncRNAs and may act as a novel potential therapeutic target for hypertrophic scar.

This publication has 32 references indexed in Scilit: